Copyright
©The Author(s) 2021.
World J Cardiol. Aug 26, 2021; 13(8): 325-339
Published online Aug 26, 2021. doi: 10.4330/wjc.v13.i8.325
Published online Aug 26, 2021. doi: 10.4330/wjc.v13.i8.325
Arrhythmia |
Cardiomyopathy |
Cardiotoxic drug |
CKD |
Congenital heart disease |
DM |
Hypertensive heart disease |
Hypertension |
Infection |
Ischemic heart disease |
Myocardial disease |
Pericardial disease |
Pulmonary hypertension |
Systemic toxins |
Valvular disease |
- Citation: Usuda D, Higashikawa T, Hotchi Y, Usami K, Shimozawa S, Tokunaga S, Osugi I, Katou R, Ito S, Yoshizawa T, Asako S, Mishima K, Kondo A, Mizuno K, Takami H, Komatsu T, Oba J, Nomura T, Sugita M. Angiotensin receptor blocker neprilysin inhibitors. World J Cardiol 2021; 13(8): 325-339
- URL: https://www.wjgnet.com/1949-8462/full/v13/i8/325.htm
- DOI: https://dx.doi.org/10.4330/wjc.v13.i8.325